NINDS encourages small business grant applications to develop advanced tools and technologies for cerebrospinal fluid (CSF) shunts. This announcement is supported by 2 funding mechanisms: R41/R42 and R43/R44.
CSF shunts have been successfully used to treat hydrocephalus for more than 50 years and are the most common treatment option for this disorder. While CSF shunts have enhanced the quality of life for many individuals, shunt obstruction and malfunction continue to be issues for a significant number of people. The purpose of this initiative is to encourage the development of: 1) monitoring and diagnostic tools for determining and/or controlling CSF shunt function, and 2) improving CSF shunt design and materials to decrease shunt failure rates.
Potential applicants should contact Stephanie Fertig, program analyst, Repair and Plasticity Cluster, NINDS; telephone: 301-496-1447; email: email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PA-09-205.html and http://grants.nih.gov/grants/guide/pa-files/PA-09-206.html.